Home › Kanser sa Bato (Renal Cell Carcinoma) › Massachusetts › Boston

Pag-aaral pangklinika para sa Kanser sa Bato (Renal Cell Carcinoma) sa Boston, MA

16 pag-aaral para sa Kanser sa Bato (Renal Cell Carcinoma) ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Boston (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Nagre-recruitPhase 1

Research Site, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05536141

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Nagre-recruitPhase 1

Exelixis Clinical Site #7, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05176483

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Nagre-recruitPhase 1/2

Tufts Medical Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Nagre-recruitPhase 2

Massachusetts General Hospital Cancer Center, Boston
Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Nagre-recruitPhase 1/2

Brigham and Women's Hospital, Boston
Dana Farber/Mass General Brigham Cancer Care, Inc, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07227415

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Nagre-recruitPhase 3

Tufts Medical Center, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06661720

A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma

Nagre-recruitPhase 2

Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07123090

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06966024

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07195682

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT03972657

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 8, 2026 · NCT06026410

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Nagre-recruitPhase 1

Beth Israel Deaconess Medical Center /ID# 252009, Boston
Dana-Farber Cancer Institute /ID# 249642, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT04777994

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

Nagre-recruitPhase 2

Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update May 20, 2026 · NCT06053658

Drug Screening Using Novel IMD in Renal Cell Carcinoma

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT05700461

Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC

Nagre-recruitPhase 2

Beth Israel Deaconess Medical Center, Boston
Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT07397611

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 15, 2024 · NCT04787042

Pag-aaral para sa Kanser sa Bato (Renal Cell Carcinoma) sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.